Usana Health Sciences

USNA

Market cap $362M

SALT LAKE CITY , Nov. 11, 2025 /PRNewswire/ -- USANA (NYSE: USNA), the global leader in cellular nutrition, is thrilled to announce that its fan-favorite MagneCal D supplement has officially earned the coveted ConsumerLab.com Seal of Approval—a gold-standard recognition for purity, potency, and scientific excellence.* With millions of Americans looking for ways to maintain their bone density, getting enough calcium, magnesium, and vitamin D isn't just a good idea—it's essential.

Community-wide effort addresses growing food insecurity among Utah children and families SALT LAKE CITY , Nov. 6, 2025 /PRNewswire/ -- In a powerful response to growing food insecurity affecting Utah families and the recent federal SNAP cutbacks, the USANA Foundation joined forces with community partners and volunteers on Wednesday, November 5, to assemble 3,000 bags of food for children and families facing food insecurity. The large-scale event, held at the USANA Foundation Headquarters in West Valley City, brought together hundreds of volunteers from organizations including the Bountiful Food Pantry, For the Kids, the Utah Department of Cultural and Community Engagement, and Kristen Andrus' Gathering for Impact.

SALT LAKE CITY , Nov. 3, 2025 /PRNewswire/ -- As business leaders worldwide focus on re-energizing workforces after years of upheaval, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is urging CEOs to lead with renewed authenticity, empathy, and moral clarity—principles he calls "the real foundation of sustainable success." "No doubt, technology and strategy will always matter," Guest said.

NEW YORK , Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE: KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE: USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30.

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Andrew Masuda - Director of Investor Relations Jim Brown - CEO & President Brent Neidig - Chief Commercial Officer G. Hekking - Chief Financial Officer Walter Noot - Chief Operating Officer Kathryn Armstrong Conference Call Participants Anthony Lebiedzinski - Sidoti & Company, LLC Susan Anderson - Canaccord Genuity Corp., Research Division Ivan Feinseth - Tigress Financial Partners LLC, Research Division Presentation Operator Greetings, and welcome to the USANA Health Sciences third quarter earnings call.

USANA Health Sciences (USNA) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.56 per share a year ago.

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025. Key Financial Results Third Quarter 2025 vs. Third Quarter 2024 Net sales of $214 million versus $200 million, representing 7% year-over-year growth. Net loss of -$6.5 million versus net earnings of $10.6 million. Diluted EPS of -$0.36 as compared with $0.56. Adjusted diluted EPS(1) of -$0.15 as compared with $0.56. Adjusted EBITDA(2).

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) (“the Company,” “USANA”) today announced that it has updated the timing of the release of its third quarter 2025 financial results, which had previously been scheduled for Tuesday, October 21, 2025. The Company will now report third quarter 2025 financial results after the close of market on Wednesday, October 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management C.

SALT LAKE CITY , Oct. 16, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, is bringing a little more sunshine to wellness. Its top-rated Vitamin D supplement has officially earned the prestigious ConsumerLab.com Seal of Approval—a recognition reserved for products that deliver on purity, potency, and scientific precision.

USANA Health Sciences faces short-term pain as Q3 preliminary results reveal declining profitability despite modest sales growth and ongoing business transition. USNA's new Brand Partner compensation plan and Hiya acquisition are causing temporary disruptions, but management expects double-digit Hiya growth and operational improvements by 2026. Valuation remains attractive, with USNA trading at significant discounts to sector averages, supported by a strong balance sheet and no debt.